Charles Grob

Charles S. Grob, M.D., is Professor of Psychiatry and Pediatrics at the UCLA School of Medicine and Director of the Division of Child and Adolescent Psychiatry at Harbor-UCLA Medical Center. He conducted the first government-approved study of MDMA, and was the principal investigator of an international biomedical psychiatric research project in the Brazilian Amazon of the plant, ayahuasca. He is currently conducting an investigation of the effects of psilocybin on anxiety in cancer patients. Dr. Grob has published numerous articles in medical and psychiatric journals and collected volumes, and is the editor of Hallucinogens: A Reader. He is a founding board member of the Heffter Research Institute.

Research Interest:

• Areas of Research Focus: Psychopharmacology of Hallucinogens & MDMA, Safety & Efficacy of Antidepressant Treatments in Children & Adolescents, and Youth Substance Abuse

Publications

A selected list of publications:

• Anderson Brian T, Labate Beatriz C, Meyer Matthew, Tupper Kenneth W, Barbosa Paulo C R, Grob Charles S, Dawson Andrew, McKenna Dennis Statement on ayahuasca The International journal on drug policy, 2012; 23(3): 173-5.
• Asarnow Joan Rosenbaum, Baraff Larry J, Berk Michele, Grob Charles S, Devich-Navarro Mona, Suddath Robert, Piacentini John C, Rotheram-Borus Mary Jane, Cohen Daniel, Tang Lingqi An emergency department intervention for linking pediatric suicidal patients to follow-up mental health treatment Psychiatric services (Washington, D.C.), 2011; 62(11): 1303-9.
• Grob Charles S, Danforth Alicia L, Chopra Gurpreet S, Hagerty Marycie, McKay Charles R, Halberstadt Adam L, Greer George R Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer Archives of general psychiatry, 2011; 68(1): 71-8.
• Callaway J C, Grob Charles S, McKenna Dennis J, Nichols David E, Shulgin Alexander, Tupper Kenneth W A demand for clarity regarding a case report on the ingestion of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) in an Ayahuasca preparation Journal of analytical toxicology, 2010; 30(6): 406-7; author reply 407.
• Griffths Roland R, Grob Charles S Hallucinogens as medicine Scientific American, 2010; 303(6): 76-9.
• Asarnow Joan Rosenbaum, Baraff Larry J, Berk Michele, Grob Charles, Devich-Navarro Mona, Suddath Robert, Piacentini John, Tang Lingqi Pediatric emergency department suicidal patients: two-site evaluation of suicide ideators, single attempters, and repeat attempters Journal of the American Academy of Child and Adolescent Psychiatry, 2008; 47(8): 958-66.
• Chang Linda, Ernst Thomas, Speck Oliver, Grob Charles S Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities The American journal of psychiatry, 2005; 162(2): 361-9.
• de Rios Marlene Dobkin, Grob Charles S, Lopez Enrique, da Silviera Dartiu Xavier, Alonso Luisa K, Doering-Silveira Evelyn Ayahuasca in adolescence: Qaualitative results Journal of psychoactive drugs, 2005; 37(2): 135-9.
• Doering-Silveira Evelyn, Lopez Enrique, Grob Charles S, de Rios Marlene Dobkin, Alonso Luisa K, Tacla Cristiane, Shirakawa Itiro, Bertolucci Paulo H, Da Silveira Dartiu X Ayahuasca in adolescence: a neuropsychological assessment Journal of psychoactive drugs, 2005; 37(2): 123-8.
• Da Silveira Dartiu Xavier, Grob Charles S, de Rios Marlene Dobkin, Lopez Enrique, Alonso Luisa K, Tacla Cristiane, Doering-Silveira Evelyn Ayahuasca in adolescence: a preliminary psychiatric assessment Journal of psychoactive drugs, 2005; 37(2): 129-33.
• de Rios Marlene Dobkin, Grob Charles S Ayahuasca use in cross-cultural perspective Journal of psychoactive drugs, 2005; 37(2): 119-21.
• Chang Linda, Cloak Christine, Patterson Kari, Grob Charles, Miller Eric N, Ernst Thomas Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response Biological psychiatry, 2005; 57(9): 967-74.
• Doering-Silveira Evelyn, Grob Charles S, de Rios Marlene Dobkin, Lopez Enrique, Alonso Luisa K, Tacla Cristiane, Da Silveira Dartiu Xavier Report on psychoactive drug use among adolescents using ayahuasca within a religious context Journal of psychoactive drugs, 2005; 37(2): 141-4.
• de Rios Marlene Dobkin, Grob Charles S, Baker John R Hallucinogens and redemption Journal of psychoactive drugs, 2003; 34(3): 239-48.
• Back-Madruga Carla, Boone Kyle B, Chang Linda, Grob Charles S, Lee Allison, Nations Heather, Poland Russell E Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users The Clinical neuropsychologist, 2003; 17(4): 446-59.
• Grob Charles S The politics of Ecstasy Journal of psychoactive drugs, 2003; 34(2): 143-4.